'Insulin glargine' presentation slideshows

Effective Use of Insulin in Diabetes: Update for 2007

Effective Use of Insulin in Diabetes: Update for 2007. Thomas M. Flood, MD Director Georgia Center for Diabetes Atlanta, Georgia. ?. Key Question. Completely comfortable Somewhat comfortable Slightly comfortable Not comfortable at all Use your keypad to vote now!.

851 views • 59 slides

Antidiabetic Drugs

Antidiabetic Drugs. Nursing 3703 Pharmacology By Linda Self. Diabetes Mellitus. Chronic systemic disease characterized by metabolic and vascular abnormalities Disorder of carbohydrate metabolism Results from inadequate production or underutilization of insulin. Diabetes Mellitus.

1.58k views • 52 slides

Preconception in D.M

Preconception in D.M. Dr.Ozra.Akha , Endocrinologist Faculty of Mazandaran university. Introduction. Pregestational and preexisting diabetes refer to type 1 or type 2 diabetes mellitus diagnosed prior to a woman's pregnancy.

531 views • 50 slides

Cardiovascular safety of insulin therapy

Cardiovascular safety of insulin therapy. F. Hosseinpanah, M.D. Obesity Research Center Research Institute for Endocrine sciences Shahid Beheshti University of Medical Sciences 10-August -2017. Agenda. Introduction Observational studies RCTs Conclusion.

475 views • 47 slides

GO! Diabetes Train the Trainer Program

GO! Diabetes Train the Trainer Program. Glycemic Control - Injected Therapies.

920 views • 44 slides

Journal Club

Journal Club. Aschner P, Chan J, Owens DR, Picard S, Wang E, Dain MP, Pilorget V, Echtay A, Fonseca V; EASIE investigators.

873 views • 42 slides

Journal Club

Journal Club. Zinman B, Fulcher G, Rao PV, Thomas N, Endahl LA, Johansen T, Lindh R, Lewin A, Rosenstock J, Pinget M, Mathieu C .

966 views • 42 slides

Hypoglycaemia

Hypoglycaemia. Definition of hypoglycaemia. When the level of glucose falls in the blood so that the cells in the periphery, and eventually the brain cells, do not get adequate glucose to function. Endogenous insulin secretion suppressed

544 views • 38 slides

In the name of GOD

In the name of GOD. New advancement in basal insulins. F.Sarvghadi MD Endocrinologist Research Institute for Endocrine sciences Shahid Beheshti Universityof Medical Sciences Tehran 95.11.28. Agenda. Introduction Basal insulin therapy: An historical overview

366 views • 36 slides

Practical Considerations in Clinical Management

264 views • 24 slides

"Type 1 Diabetes & Pharmacology: Precaution Adoption Process" Online Course on Udemy

Free Preview Lecture "Type 1 Diabetes & Pharmacology: Precaution Adoption Process" Online Course on Udemy Discount Coupon: https://www.udemy.com/type-1-diabetes-pharmacology-precaution-adoption-process/?couponCode=TYPEONEDIABETES What you'll learn: Precaution Adoption Process Model (PAPM), Structures of the PAPM, Pathogenesis and Prognosis of Type 1 Diabetes, A1C Standard and Risk of having Diabetes: Diagnostic Examinations for Diabetes, Impaired fasting glucose (IFG) and Impaired glucose tolerance (IGT), Aims of Medical nutrition treatment, Insulin analogues: Management and Posology, and Developing Medicinal Adherence. Who this course is for: People from whole of the world, who have an interest in the following approaches: 1) Precaution Adoption Process Model, 2) Pathology, 3) Laboratory Sciences, 4) Nutrition, 5) Health Behavior, 6) Health Education, 7) Health and Risk Management, 8) Health Psychology, 9) Clinical Pharmacology, 10) Diabetes Care, 11) Health Promotion, 12) Nutrition, 13) Endocrinology and Metabolism, 14) Medical Sciences, 15) Clinical Pharmacokinetics, 16) Autoimmunity, 17) Clinical Chemistry, 18) Clinical Therapy, and 19) Biochemistry. And this course contains fifty-seven resource. By Maram Abdel Nasser Taha Shtaya - Pharmacist and American Studies Instructor who is teaching on Udemy.

177 views • 17 slides

INSULIN ANALOGS WITH EXTENDED TIME-ACTION AND HIGH SELECTIVITY FOR INSULIN vs IGF-1 RECEPTOR

INSULIN ANALOGS WITH EXTENDED TIME-ACTION AND HIGH SELECTIVITY FOR INSULIN vs IGF-1 RECEPTOR

309 views • 15 slides

Featured Article :

Featured Article :. Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes.

296 views • 14 slides

Insulin analogues: Management and Posology | Online Course | Udemy

Free Preview Lecture "Type 1 Diabetes & Pharmacology: Precaution Adoption Process" Online Course on Udemy Discount Coupon: https://www.udemy.com/type-1-diabetes-pharmacology-precaution-adoption-process/?couponCode=TYPEONEDIABETES What you'll learn: Precaution Adoption Process Model (PAPM), Structures of the PAPM, Pathogenesis and Prognosis of Type 1 Diabetes, A1C Standard and Risk of having Diabetes: Diagnostic Examinations for Diabetes, Impaired fasting glucose (IFG) and Impaired glucose tolerance (IGT), Aims of Medical nutrition treatment, Insulin analogues: Management and Posology, and Developing Medicinal Adherence. Who this course is for: People from whole of the world, who have an interest in the following approaches: 1) Precaution Adoption Process Model, 2) Pathology, 3) Laboratory Sciences, 4) Nutrition, 5) Health Behavior, 6) Health Education, 7) Health and Risk Management, 8) Health Psychology, 9) Clinical Pharmacology, 10) Diabetes Care, 11) Health Promotion, 12) Nutrition, 13) Endocrinology and Metabolism, 14) Medical Sciences, 15) Clinical Pharmacokinetics, 16) Autoimmunity, 17) Clinical Chemistry, 18) Clinical Therapy, and 19) Biochemistry. And this course contains fifty-seven resource. By Maram Abdel Nasser Taha Shtaya - Pharmacist and American Studies Instructor who is teaching on Udemy.

129 views • 11 slides

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With

Featured Article :. Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine A 24-Week, Randomized, Placebo-Controlled Study (GetGoal-Duo 1).

171 views • 10 slides

441 views • 10 slides

New Insulin Formulations

New Insulin Formulations. Guillermo Umpierrez, MD, FACP, FACE Professor of Medicine Emory University School of Medicine Part 1. BANTING-1891-1941 & BEST-1899-1978. First commercial insulin. Milestones in Insulin Development. Insulin lispro approved in US (1996).

167 views • 10 slides

Daily Equity Report 04 OCT 2019

Bullion Premium is one of our premium services. In this service, we provide 3-5 calls in MCX include mcx commodity tips, MCX Bullions, and Mcx live tips, Mcx tips. http://www.capitalstars.com/bullion-premium-mcx-tips/ https://www.youtube.com/watch?v=GlKYauahgHI

83 views • 8 slides

Worldwide Insulin Glargine Market Key Manufacturers Analysis 2017

The research study Global Insulin Glargine Market Research Report 2017 is the latest addition to the repository of DecisionDatabases.com.The report covers the complete industry outlook and market prospective.

116 views • 7 slides

T1DM: Insulin Initiation

T1DM: Insulin Initiation. Recommended to start conservatively at approximately 0.5 units/kg/day ( Range: 0.4-1.0 units/kg/day). Calculate TDD. ~50%. ~50%. Total Basal Insulin Dose. Total Prandial/Basal Dose. Lunch. Dinner. Breakfast. TDD : Total Daily Dose (insulin).

86 views • 7 slides